This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meyer, D. E. Articles by Chilkoti, A. Search for Related Content PubMed PubMed Citation Articles by Meyer, D. E. Articles by Chilkoti, A.

Targeting a Genetically Engineered Elastin-like Polypeptide to Solid Tumors by Local Hyperthermia¹

Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708 [D. E. M., G. A. K., A. C.], and Departments of Radiation Oncology [M. W. D.] and Radiology [M. R. Z.], Duke University Medical Center, Durham, North Carolina 27710

Elastin-like polypeptides (ELPs) are biopolymers of the pentapeptide repeat Val-Pro-Gly-Xaa-Gly that undergo an inverse temperature phase transition. They are soluble in aqueous solutions below their transition temperature (T_t) but hydrophobically collapse and aggregate at temperatures greater than T_t. We hypothesized that ELPs conjugated to drugs would enable thermally targeted drug delivery to solid tumors if their T_t were between body temperature and the temperature in a locally heated region. To test this hypothesis, we synthesized a thermally responsive ELP with a T_t of 41°C and a thermally unresponsive control ELP in Escherichia coli using recombinant DNA techniques. In vivo fluorescence videomicroscopy and radiolabel distribution studies of ELP delivery to human tumors (SKOV-3 ovarian carcinoma and D-54MG glioma) implanted in nude mice demonstrated that hyperthermic targeting of the thermally responsive ELP for 1 h provides a 2-fold increase in tumor localization compared to the same polypeptide without hyperthermia. We observed aggregates of the thermally responsive ELP by fluorescence videomicroscopy within the heated tumor microvasculature but not in control experiments, which demonstrates that the phase transition of the thermally responsive ELP carrier can be engineered to occur in vivo at a specified temperature. By exploiting the phase transition-induced aggregation of these polypeptides, this method provides a new way to thermally target polymer-drug conjugates to solid tumors.

This article has been cited by other articles:

				M. R. Dreher and A. Chilkoti Toward a Systems Engineering Approach to Cancer Drug Delivery J Natl Cancer Inst, July 4, 2007; 99(13): 983 - 985. [Full Text] [PDF]

				M. R. Dreher, W. Liu, C. R. Michelich, M. W. Dewhirst, and A. Chilkoti Thermal Cycling Enhances the Accumulation of a Temperature-Sensitive Biopolymer in Solid Tumors Cancer Res., May 1, 2007; 67(9): 4418 - 4424. [Abstract] [Full Text] [PDF]

				K. Chockalingam, M. Blenner, and S. Banta Design and application of stimulus-responsive peptide systems Protein Eng. Des. Sel., April 1, 2007; 20(4): 155 - 161. [Abstract] [Full Text] [PDF]

				G. L. Bidwell III and D. Raucher Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy Mol. Cancer Ther., July 1, 2005; 4(7): 1076 - 1085. [Abstract] [Full Text] [PDF]

				K. Trabbic-Carlson, D.E. Meyer, L. Liu, R. Piervincenzi, N. Nath, T. LaBean, and A. Chilkoti Effect of protein fusion on the transition temperature of an environmentally responsive elastin-like polypeptide: a role for surface hydrophobicity? Protein Eng. Des. Sel., January 1, 2004; 17(1): 57 - 66. [Abstract] [Full Text] [PDF]

				V. Chtryt and K. Ulbrich Conjugate of Doxorubicin with a Thermosensitive Polymer Drug Carrier Journal of Bioactive and Compatible Polymers, November 1, 2001; 16(6): 427 - 440. [Abstract] [PDF]

				D. Raucher and A. Chilkoti Enhanced Uptake of a Thermally Responsive Polypeptide by Tumor Cells in Response to Its Hyperthermia-mediated Phase Transition Cancer Res., October 1, 2001; 61(19): 7163 - 7170. [Abstract] [Full Text] [PDF]